JPMorgan Is The Rally Over?
JPMorgan Chase (NYSE:JPM) share price is up 29% over the…
Buy
58
HLNCF Quote, Financials, Valuation and Earnings
Last price:
$5.2300
Seasonality move
:
-2.32%
Day range:
$5.0600 - $5.2300
52-week range:
$3.9000 - $5.4700
Dividend yield:
1.52%
P/E ratio:
26.00x
P/S ratio:
3.34x
P/B ratio:
2.33x
Volume:
757
Avg. volume:
33.5K
1-year change:
32.74%
Market cap:
$47.3B
Revenue:
$14.4B
EPS (TTM):
$0.20
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Haleon PLC has -- downside to fair value with a price target of -- per share.
HLNCF vs. S&P 500
-
Over the past 5 trading days, Haleon PLC has overperformed the S&P 500 by 10.85% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Haleon PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Haleon PLC has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Haleon PLC reported revenues of $3.5B.
Earnings Growth
-
Haleon PLC has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Haleon PLC reported earnings per share of $0.03.
Enterprise value:
57.1B
EV / Invested capital:
--
Price / LTM sales:
3.34x
EV / EBIT:
19.37x
EV / Revenue:
3.98x
PEG ratio (5yr expected):
0.61x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
19.37x
Gross Profit (TTM):
$8.7B
Return On Assets:
4.3%
Net Income Margin (TTM):
12.86%
Return On Equity:
8.91%
Return On Invested Capital:
5.64%
Operating Margin:
12.69%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $14.6B | $14.1B | $14.4B | $3.4B | $3.5B | |
| Gross Profit | $8.9B | $8.4B | $8.7B | $1.8B | $2B | |
| Operating Income | $2.5B | $2.5B | $2.8B | $336.6M | $448.1M | |
| EBITDA | $2.7B | $2.6B | $2.9B | $393.7M | $510.8M | |
| Diluted EPS | $0.14 | $0.14 | $0.20 | -- | $0.03 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $7.1B | $4.9B | $6.1B | $7.2B | |
| Total Assets | -- | $46.5B | $42.1B | $43.4B | $43.1B | |
| Current Liabilities | -- | $5.7B | $5.3B | $5.9B | $7.3B | |
| Total Liabilities | -- | $10.8B | $22.2B | $22.1B | $22.7B | |
| Total Equity | -- | $35.7B | $19.9B | $21.3B | $20.4B | |
| Total Debt | -- | $1.2B | $12.4B | $11.8B | $12.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.4B | -- | -- | $937.5M | $1.1B | |
| Cash From Investing | -- | -- | -- | -$235.3M | $296.5M | |
| Cash From Financing | -- | -- | -- | -$848.6M | -$2B | |
| Free Cash Flow | -- | -- | -- | $757.3M | $921M | |
HLNCF
Sector
Market Cap
$47.3B
$258M
Price % of 52-Week High
95.61%
72.31%
Dividend Yield
1.52%
0%
Shareholder Yield
--
3.16%
1-Year Price Total Return
32.74%
-9.87%
Beta (5-Year)
--
0.416
Dividend yield:
1.52%
Annualized payout:
$0.08
Payout ratio:
26.52%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$4.8944
200-day SMA
Buy
Level
$4.7938
Bollinger Bands (100)
Buy
Level
4.5943 - 5.0543
Chaikin Money Flow
Sell
Level
-708.9K
20-day SMA
Buy
Level
$4.9673
Relative Strength Index (RSI14)
Buy
Level
58.6598
ADX Line
Sell
Level
12.2695
Williams %R
Sell
Level
-15.1163
50-day SMA
Buy
Level
$4.9828
MACD (12, 26)
Buy
Level
0.0119
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Neutral
Level
1.8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7871)
Buy
CA Score
(Annual)
Level (-0.1227)
Buy
Beneish M-Score
(Annual)
Level (-2.5081)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.1064)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Stock Forecast FAQ
In the current month, HLNCF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HLNCF average analyst price target in the past 3 months is --.
-
Where Will Haleon PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Haleon PLC share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Haleon PLC?
Analysts are divided on their view about Haleon PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Haleon PLC is a Sell and believe this share price will rise from its current level to --.
-
What Is Haleon PLC's Price Target?
The price target for Haleon PLC over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HLNCF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Haleon PLC is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HLNCF?
You can purchase shares of Haleon PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Haleon PLC shares.
-
What Is The Haleon PLC Share Price Today?
Haleon PLC was last trading at $5.2300 per share. This represents the most recent stock quote for Haleon PLC. Yesterday, Haleon PLC closed at $5.2300 per share.
-
How To Buy Haleon PLC Stock Online?
In order to purchase Haleon PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is BlackRock a Buy, Sell or Hold
With a large suite of ETF offerings as well as…
Is Uber Stock a Buy, Sell or Hold?
Uber (NYSE:UBER) has been through quite a ride over the…
Stock Ideas
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 32x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
46
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 35x
Alerts
Sell
23
UNH alert for Apr 18
UnitedHealth Group [UNH] is down 22.4% over the past day.
Sell
32
MAN alert for Apr 18
ManpowerGroup [MAN] is down 19.07% over the past day.
Sell
24
GPN alert for Apr 18
Global Payments [GPN] is down 17.44% over the past day.
